Agenus (AGEN) Capital Expenditures Growth (1y) (2011 - 2025)
Agenus (AGEN) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Agenus | 234.10 Mn | 199.10 Mn | 33.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -99.78% |
| Mar 31, 2025 | -85.71% |
| Dec 31, 2024 | -67.26% |
| Sep 30, 2024 | -99.80% |
| Jun 30, 2024 | -89.61% |
| Mar 31, 2024 | -98.10% |
| Dec 31, 2023 | 105.62% |
| Sep 30, 2023 | 271.83% |
| Jun 30, 2023 | -26.19% |
| Mar 31, 2023 | -59.46% |
| Dec 31, 2022 | -310.73% |
| Sep 30, 2022 | -297.93% |
| Jun 30, 2022 | 164.80% |
| Mar 31, 2022 | 2,218.37% |
| Dec 31, 2021 | 125.66% |
| Sep 30, 2021 | 16.67% |
| Jun 30, 2021 | 49.74% |
| Mar 31, 2021 | -20.33% |
| Dec 31, 2020 | -21.02% |
| Sep 30, 2020 | -75.11% |